Jade Biosciences, Inc.
Status: Publicly traded
Last reviewed: October 2026
Direct answer
Jade Biosciences, Inc. is publicly traded on NASDAQ under the ticker JBIO.
Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. It develops JADE101, a monoclonal antibody to block the A PRoliferation Inducing Ligand protein, which is in phase 1 clinical trial. The company also develops JADE201 and JADE-003, which are in preclinical development stage. Jade Biosciences, Inc....
Can you invest in Jade Biosciences, Inc.?
Yes. Jade Biosciences, Inc. trades publicly on NASDAQ as JBIO.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Jade Biosciences, Inc.
Detailed equity research is provided by MarketSnap.